Effects on platelet function by human interferon-beta in carcinoma patients

P. Ferroni, M. Roselli, A. Diodati, C. U. Casciani, P. P. Gazzaniga

Research output: Contribution to journalArticle


The effects of a therapeutic course of human interferon-β (Hu IFN-β) on platelet function were evaluated in 10 patients with neoplatstic disorder. Each patient received, by intramuscular route, 6 x 106 IU of Hu IFN-β every other day for 2 weeks. Platelet count, packed platelet volume, platelet size and in vitro aggregation tests were evaluated before IFN treatment and weekly during the treatment. An overall increase of in vitro platelet aggregation was present in all patients after the first week, and persisted after the second week of treatment. This effect was most pronounced when ADP and collagen were used as aggregation inducers. No significant differences were observed in IFN-γ, IL-6, IL-1β and GM-CSF serum levels before and after IFN-β treatment; nevertheless a parallel rise in IL-1β and/or GM-CSF and platelet count was noticed. The results obtained indicate that the effects of IFN-β on platelet function are most likely due to a direct influence on bone marrow.

Original languageEnglish
Pages (from-to)2779-2784
Number of pages6
JournalAnticancer Research
Issue number6 B
Publication statusPublished - 1994


  • Blood platelets
  • Cytokines
  • Human interferon-β
  • Platelet aggregation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Effects on platelet function by human interferon-beta in carcinoma patients'. Together they form a unique fingerprint.

  • Cite this

    Ferroni, P., Roselli, M., Diodati, A., Casciani, C. U., & Gazzaniga, P. P. (1994). Effects on platelet function by human interferon-beta in carcinoma patients. Anticancer Research, 14(6 B), 2779-2784.